title: [Pharmacological properties and clinical efficacy of ipilimumab, human anti-human CTLA-4 monoclonal antibody (YERVOY(®))].
authors.forename: Manabu
authors.initials: M
authors.lastname: Amano
authors.forename: Hiroko
authors.initials: H
authors.lastname: Kobayashi
authors.forename: Mayumi
authors.initials: M
authors.lastname: Hasegawa
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Otsuka
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000918:Antibody Specificity; D060908:CTLA-4 Antigen / Q000276:immunology*; D002986:Clinical Trials as Topic; D006801:Humans; D000074324:Ipilimumab; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D060908:CTLA-4 Antigen; D000074324:Ipilimumab